ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,323 | 260 | -1,506 | -419 | -35 |
| Depreciation Amortization | 291 | 145 | 567 | 425 | 281 |
| Accounts receivable | -995 | -472 | -327 | -518 | -32 |
| Other Working Capital | -1,591 | -661 | -127 | -546 | -693 |
| Other Operating Activity | 5,630 | 494 | 1,256 | 1,480 | 1,035 |
| Operating Cash Flow | $-988 | $-234 | $-137 | $422 | $556 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -128 | -108 | -292 | -77 | -69 |
| Other Investing Activity | 18,198 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $18,070 | $-108 | $-292 | $-77 | $-69 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | -433 | N/A | N/A | 0 | N/A |
| Other Financing Activity | -4,065 | 372 | 440 | -196 | -367 |
| Financing Cash Flow | $-4,498 | $372 | $440 | $-196 | $-367 |
| Beginning Cash Position | 11 | 11 | N/A | N/A | N/A |
| End Cash Position | 12,595 | 41 | 11 | 148 | 120 |
| Net Cash Flow | $12,584 | $30 | $11 | $148 | $120 |
| Free Cash Flow | |||||
| Operating Cash Flow | -988 | -234 | -137 | 422 | 556 |
| Capital Expenditure | -128 | -108 | -292 | -77 | -69 |
| Free Cash Flow | -1,116 | -342 | -429 | 345 | 487 |